Clinical Trial Update: A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma [Phase 1]

View source ↗

Summary

A Phase 1 randomized, double-blind, placebo-controlled study evaluating AMG 691 in healthy participants and in individuals with mild-to-moderate asthma; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AMG 691

Snippet

Sponsor: Amgen | Conditions: Asthma | Phase 1 | Status: RECRUITING